113 related articles for article (PubMed ID: 9723150)
1. Lower serum activity of prolyl endopeptidase in fibromyalgia is related to severity of depressive symptoms and pressure hyperalgesia.
Maes M; Libbrecht I; Van Hunsel F; Lin AH; Bonaccorso S; Goossens F; De Meester I; De Clerck L; Biondi M; Scharpe S; Janca A
Psychol Med; 1998 Jul; 28(4):957-65. PubMed ID: 9723150
[TBL] [Abstract][Full Text] [Related]
2. Effects of psychological stress on serum prolyl endopeptidase and dipeptidyl peptidase IV activity in humans: higher serum prolyl endopeptidase activity is related to stress-induced anxiety.
Maes M; Goossens F; Lin A; De Meester I; Van Gastel A; Scharpé S
Psychoneuroendocrinology; 1998 Jul; 23(5):485-95. PubMed ID: 9802123
[TBL] [Abstract][Full Text] [Related]
3. Prolyl endopeptidase and dipeptidyl peptidase IV are associated with externalizing and aggressive behaviors in normal and autistic adolescents.
Frenssen F; Croonenberghs J; Van den Steene H; Maes M
Life Sci; 2015 Sep; 136():157-62. PubMed ID: 26165750
[TBL] [Abstract][Full Text] [Related]
4. Serum activities of adenosine deaminase, dipeptidyl peptidase IV and prolyl endopeptidase in patients with fibromyalgia: diagnostic implications.
Čulić O; Cordero MD; Žanić-Grubišić T; Somborac-Bačura A; Pučar LB; Detel D; Varljen J; Barišić K
Clin Rheumatol; 2016 Oct; 35(10):2565-71. PubMed ID: 27527091
[TBL] [Abstract][Full Text] [Related]
5. Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs.
Maes M; De Meester I; Scharpe S; Desnyder R; Ranjan R; Meltzer HY
Acta Psychiatr Scand; 1996 Jan; 93(1):1-8. PubMed ID: 8919323
[TBL] [Abstract][Full Text] [Related]
6. Lower activity of serum peptidases in abstinent alcohol-dependent patients.
Maes M; Lin A; Bonaccorso S; Vandoolaeghe E; Song C; Goossens F; De Meester I; Degroote J; Neels H; Scharpé S; Janca A
Alcohol; 1999 Jan; 17(1):1-6. PubMed ID: 9895030
[TBL] [Abstract][Full Text] [Related]
7. Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-alpha in high-risk melanoma patients.
Van Gool AR; Van Ojik HH; Kruit WH; Mulder PG; Fekkes D; Bannink M; Scharpé S; Stoter G; Eggermont AM; Maes M; Verkerk R
J Interferon Cytokine Res; 2004 Jul; 24(7):411-5. PubMed ID: 15296652
[TBL] [Abstract][Full Text] [Related]
8. Lower activities of serum peptidases predict higher depressive and anxiety levels following interferon-alpha-based immunotherapy in patients with hepatitis C.
Maes M; Bonaccorso S
Acta Psychiatr Scand; 2004 Feb; 109(2):126-31. PubMed ID: 14725594
[TBL] [Abstract][Full Text] [Related]
9. Presence of dipeptidyl peptidase II, dipeptidyl peptidase IV, and prolyl endopeptidase in effusion from patients with serous otitis media.
Rao AJ; Hagihara M; Nagatsu T; Yanagita N
Biochem Med Metab Biol; 1990 Jun; 43(3):276-82. PubMed ID: 1974452
[TBL] [Abstract][Full Text] [Related]
10. Components of biological variation in prolyl endopeptidase and dipeptidyl-peptidase IV activity in plasma of healthy subjects.
Maes M; Scharpé S; De Meester I; Goossens P; Wauters A; Neels H; Verkerk R; De Meyer F; D'Hondt P; Peeters D
Clin Chem; 1994 Sep; 40(9):1686-91. PubMed ID: 7915215
[TBL] [Abstract][Full Text] [Related]
11. Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression.
Maes M; Goossens F; Scharpé S; Meltzer HY; D'Hondt P; Cosyns P
Biol Psychiatry; 1994 Apr; 35(8):545-52. PubMed ID: 8038298
[TBL] [Abstract][Full Text] [Related]
12. Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation.
Maes M; Bonaccorso S; Marino V; Puzella A; Pasquini M; Biondi M; Artini M; Almerighi C; Meltzer H
Mol Psychiatry; 2001 Jul; 6(4):475-80. PubMed ID: 11443537
[TBL] [Abstract][Full Text] [Related]
13. Distribution of peptidases in cultured cells from middle ear mucosa: prolyl endopeptidase is localized in fibroblasts and dipeptidyl peptidase IV and II in epithelial cells.
Avasarala JR; Naoi M; Sasaki S; Ueda M; Saga S; Suzuki T; Yanagita N; Nagatsu T
Biochem Med Metab Biol; 1991 Jun; 45(3):355-8. PubMed ID: 1675574
[TBL] [Abstract][Full Text] [Related]
14. Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: relationships with immune-inflammatory markers.
Maes M; De Meester I; Verkerk R; De Medts P; Wauters A; Vanhoof G; Vandoolaeghe E; Neels H; Scharpé S
Psychoneuroendocrinology; 1997 Feb; 22(2):65-78. PubMed ID: 9149329
[TBL] [Abstract][Full Text] [Related]
15. Identification of altered dipeptidyl-peptidase activities as potential biomarkers for unipolar depression.
Deng J; Lamb JR; Mckeown AP; Miller S; Muglia P; Guest PC; Bahn S; Domenici E; Rahmoune H
J Affect Disord; 2013 Nov; 151(2):667-672. PubMed ID: 23948634
[TBL] [Abstract][Full Text] [Related]
16. Effects of pregnancy and delivery on serum prolyl endopeptidase (PEP) activity: alterations in serum PEP are related to increased anxiety in the early puerperium and to postpartum depression.
Maes M; Libbrecht I; Lin A; Goossens F; Ombelet W; Stevens K; Bosmans E; Altamura C; Cox J; de Jongh R; Scharpé S
J Affect Disord; 2000; 57(1-3):125-37. PubMed ID: 10708824
[TBL] [Abstract][Full Text] [Related]
17. Lower serum activity of prolyl endopeptidase in anorexia and bulimia nervosa.
Maes M; Monteleone P; Bencivenga R; Goossens F; Maj M; van West D; Bosmans E; Scharpe S
Psychoneuroendocrinology; 2001 Jan; 26(1):17-26. PubMed ID: 11070331
[TBL] [Abstract][Full Text] [Related]
18. Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs.
Maes M; Goossens F; Scharpé S; Calabrese J; Desnyder R; Meltzer HY
Psychiatry Res; 1995 Oct; 58(3):217-25. PubMed ID: 8570777
[TBL] [Abstract][Full Text] [Related]
19. Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy.
Maes M; Capuron L; Ravaud A; Gualde N; Bosmans E; Egyed B; Dantzer R; Neveu PJ
Neuropsychopharmacology; 2001 Feb; 24(2):130-40. PubMed ID: 11120395
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine and immune aspects of fibromyalgia.
van West D; Maes M
BioDrugs; 2001; 15(8):521-31. PubMed ID: 11543693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
